Why the study?
Does rapamycin reduce fractional cell shortening and alter contractility in isolated human cardiomyocytes?
Does rapamycin reduce fractional cell shortening and alter contractility in isolated human cardiomyocytes?
Rapamycin exerts an acute negative inotropic effect on isolated human cardiomyocytes, likely due to altered calcium homeostasis.
Answers are grounded in this paper and cite their sources.
May impair contractility in isolated cardiomyocytes; leaves open in vivo effects and clinical relevance.
Rapamycin is an increasingly important immunosuppressive drug and reduces restenosis after coronary stenting, but its effects on cardiac contractility are largely unknown. We investigated the acute inotropic effects of rapamycin on isolated human cardiomyocytes. Cardiomyocytes were enzymatically isolated from right atrial appendages obtained during routine coronary artery bypass surgery. Cell morphology was examined by confocal microscopy. Cell contraction was recorded after electrical stimulation. Rapamycin elicited a concentration-dependent decrease in fractional cell shortening ranging from 14.3 +/- 2.6% at 10(-8) M rapamycin to 26.4 +/- 4.2% at 10(-5) M. Rapamycin also caused a concentration-dependent decrease in diastolic cell length. Contractile performance of isolated cardiomyocytes was well preserved, as evidenced by the profound positive inotropic effects of high extracellular calcium concentration and the beta-adrenoreceptor agonist isoproterenol. The acute negative inotropic effect of rapamycin on human cardiomyocytes might be due to altered calcium homeostasis through the binding of rapamycin to FKBP12.6 and its regulatory function on the ryanodine receptor, with increased calcium leakage from the sarcoplasmic reticulum.
No takes yet. Share an insight, caveat, or question.
Möllmann et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: